514 related articles for article (PubMed ID: 24607904)
1. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
2. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
[TBL] [Abstract][Full Text] [Related]
3. SOX5 promotes epithelial-mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma.
Wang D; Han S; Wang X; Peng R; Li X
Med Oncol; 2015 Feb; 32(2):461. PubMed ID: 25572815
[TBL] [Abstract][Full Text] [Related]
4. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
[TBL] [Abstract][Full Text] [Related]
5. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
Nam EH; Lee Y; Moon B; Lee JW; Kim S
Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
[TBL] [Abstract][Full Text] [Related]
7. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.
Chen M; Zou S; He C; Zhou J; Li S; Shen M; Cheng R; Wang D; Zou T; Yan X; Huang Y; Shen J
Carcinogenesis; 2020 Jul; 41(5):551-560. PubMed ID: 31713604
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
[TBL] [Abstract][Full Text] [Related]
11. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
12. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
13. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
14. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
[TBL] [Abstract][Full Text] [Related]
16. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
17. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
[TBL] [Abstract][Full Text] [Related]
18. FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.
Chen D; Wang R; Yu C; Cao F; Zhang X; Yan F; Chen L; Zhu H; Yu Z; Feng J
EBioMedicine; 2019 Jun; 44():150-161. PubMed ID: 31147293
[TBL] [Abstract][Full Text] [Related]
19. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
Chen SY; Teng SC; Cheng TH; Wu KJ
Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
[TBL] [Abstract][Full Text] [Related]
20. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
Wang J; Wang X; Liu F; Fu Y
Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
